Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development—A Drug Developer's Perspective

IMAGING THE ENZYME 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 WITH POSITRON EMISSION TOMOGRAPHY: EVALUATION OF THE NOVEL RADIOTRACER 11C-AS2471907 IN HUMAN BRAIN

(2019) Jean-Dominique Gallezot et al.   JOURNAL OF NUCLEAR MEDICINE

The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia

(2019) Jack Cotter et al.   Frontiers in Psychiatry

A narrative meta-synthesis of how people with schizophrenia experience facilitators and barriers in using antipsychotic medication – Implications for healthcare professionals

(2018) Martin Salzmann-Erikson et al.   INTERNATIONAL JOURNAL OF NURSING STUDIES

Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge

(2018) Neal R. Swerdlow et al.   SCHIZOPHRENIA RESEARCH

Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

(2017) Dawn I Velligan et al.   Patient Preference and Adherence

Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia

(2014) Helena Fatouros-Bergman et al.   SCHIZOPHRENIA RESEARCH

The global cognitive impairment in schizophrenia: Consistent over decades and around the world

(2013) Jonathan Schaefer et al.   SCHIZOPHRENIA RESEARCH

Diagnosing the decline in pharmaceutical R&D efficiency

(2012) Jack W. Scannell et al.   NATURE REVIEWS DRUG DISCOVERY

Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival

(2011) Paul Morgan et al.   DRUG DISCOVERY TODAY

Networking for new drugs

(2011) Claire Ainsworth   NATURE MEDICINE

Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?

(2011) Richard S. E. Keefe et al.   SCHIZOPHRENIA BULLETIN

Proof of Concept: A PhRMA Position Paper With Recommendations for Best Practice

(2010) M E Cartwright et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cognitive and symptomatic predictors of functional disability in schizophrenia

(2010) Syed Shamsi et al.   SCHIZOPHRENIA RESEARCH

The Burden of Schizophrenia on Caregivers

(2009) A George Awad et al.   PHARMACOECONOMICS

Schizophrenia, “just the facts” 4. Clinical features and conceptualization

(2009) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH